Whalegun
Home

Jonathan Zalevsky, Chief R&D Officer: Nektar Therapeutics NKTR Sell · Filed 23/08/17

Trade details

Type
Insider sale
Amount
$7,568.34
Shares · price
9,703 sh · $0.78 a share
Held after
283,685 sh
Stock
Nektar Therapeutics NKTR
Person
Jonathan ZalevskyChief R&D Officer
Trade date
23/08/16
Filed
23/08/17
Days to filing
1 days

Sold 3.3% of holdings

Share of holding sold
3.3%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/17~23/09/15

Jonathan Zalevsky's recent trades

  • Jonathan Zalevsky

    Planned saleNektar Therapeutics

    $13.4K

    Filed 08/18

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $371.5K

    Filed 06/30

  • Jonathan Zalevsky

    Sell10b5-1 planNektar Therapeutics

    $336.2K

    Filed 06/17

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $328.8K

    Filed 06/15

  • Jonathan Zalevsky

    SellNektar Therapeutics

    $13K

    Filed 05/21